Bio

Paul Owen most recently served as President and Interim CEO of imaware™ which provides a digital health platform experience that offers advanced home-based testing and monitoring. Paul has had a very productive and successful career in developing and bringing healthcare innovation to market. He previously served as Chief Business Officer and COO for Kailos Genetics and CEO of OneOme, an innovator in precision medicine and pharmacogenetics, co-founded by Mayo Clinic. While leading OneOme they were recognized by Fast Company as the top 22 of 50 most innovative companies in the world, #2 in biotech, awarded 2019 MedTech Breakthrough Award, Best Overall Genomics Company, 2018 Inc. Magazine.

Prior to joining OneOme Paul led global commercialization for Invitae, a leader in hereditary disease diagnostics testing. Previously, Paul served as Vice Chair of Global Business Development for Mayo Clinic and was the leader of Mayo Medical Laboratories’ global commercial team – one of the world’s largest full-service reference labs and held leadership roles at Zimmer-Biomet and Boston Scientific.

Expertise

Paul also serves on the Board of Directors for OpalGenix, Oncodea, and the The Redemption Project and as an Executive Advisor to the University of MN Ventures Group, Decode Health, Phenomix Sciences and Spesana. He received his B.S. in business administration from the University of Wisconsin – Stout and lives in Minneapolis, MN.